Hiroaki Shimizu

Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non–Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan

Kazuhiro Ikegame, Takashi Yoshida, Satoshi Yoshihara et al. · Biology of Blood and Marrow Transplantation · 2015 · 63 citations

Philadelphia chromosome‐positive mixed phenotype acute leukemia in the imatinib era

Hiroaki Shimizu, Akihiko Yokohama, Nahoko Hatsumi et al. · European Journal Of Haematology · 2014 · 55 citations · Full text

Hematological Malignancy, Cytogenetics, Medicine +15

Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma

Hiroaki Shimizu, Takayuki Saitoh, Masatsugu Tanaka et al. · Leukemia · 2012 · 44 citations

Hematological Malignancy, Cell Therapy, Transplantation +10

Prevalence and Risk Factor Analysis of Post-Intensive Care Syndrome in Patients with COVID-19 Requiring Mechanical Ventilation: A Multicenter Prospective Observational Study

Junji Hatakeyama, Shigeaki Inoue, Keibun Liu et al. · Journal of Clinical Medicine · 2022 · 42 citations · Full text

Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched‐pair analysis

Hiroaki Shimizu, Takayuki Saitoh, Shinichiro Machida et al. · European Journal Of Haematology · 2015 · 41 citations

Hematological Malignancy, Translational Medicine, Cell Therapy +15